M. H.艾布拉姆斯是美国当代著名的人文主义批评家和浪漫主义研究大师,其代表作《镜与灯》和《自然的超自然主义》都是英美人文主义批评经典著作。学术界对于艾氏的人文主义批评实践已有丰富的研究成果,但对于他有关人文主义批评的思想...M. H.艾布拉姆斯是美国当代著名的人文主义批评家和浪漫主义研究大师,其代表作《镜与灯》和《自然的超自然主义》都是英美人文主义批评经典著作。学术界对于艾氏的人文主义批评实践已有丰富的研究成果,但对于他有关人文主义批评的思想观点却鲜有讨论。其实,艾氏一生不仅在批评实践中坚持人文主义批评传统,还在诸多批评文献中对人文主义批评的内涵、目的和方法进行了充分的论述和阐释。在他看来,文学是“人的世界”的产品,是用“灵活、微妙”的“人文话语”表达“人性关怀”,是人际交流的一种“媒介”。文学批评的目的是追求人文真实,人文追求是永无止境的,因而文学批评的方法必须是多元的。展开更多
Brainstem gliomas comprise both slow-growing and highly aggressive tumors,the latter carrying a dismal prognosis of approximately 10 months in children.Given their common locations along the brainstem,they are often n...Brainstem gliomas comprise both slow-growing and highly aggressive tumors,the latter carrying a dismal prognosis of approximately 10 months in children.Given their common locations along the brainstem,they are often not amenable to surgical resection.There are currently a host of exploratory therapies under investigation ranging from immunotherapy,small molecular inhibitors,epigenetic-modifying agents,and radiation protocols to combat these difficult-to-treat tumors.Recent discoveries highlighting the role of H3 histone mutations in diffuse midline glioma oncogenesis have yielded a variety of new targetable antigens and aberrant signaling pathways.Although many of these studies have shown promise in terms of inhibiting tumor growth and disease progression,results to date have been modest in their ability to translate into meaningful clinical benefit.This review will serve as an updated report on the current state of literature concerning pre-clinical and clinical therapies being investigated for brainstem glioma.In addition,this review will serve as a guide for clinicians as we review the evolving nomenclature of brainstem gliomas,commonly presenting symptoms,diagnostic tools,and standard therapies.展开更多
文摘Brainstem gliomas comprise both slow-growing and highly aggressive tumors,the latter carrying a dismal prognosis of approximately 10 months in children.Given their common locations along the brainstem,they are often not amenable to surgical resection.There are currently a host of exploratory therapies under investigation ranging from immunotherapy,small molecular inhibitors,epigenetic-modifying agents,and radiation protocols to combat these difficult-to-treat tumors.Recent discoveries highlighting the role of H3 histone mutations in diffuse midline glioma oncogenesis have yielded a variety of new targetable antigens and aberrant signaling pathways.Although many of these studies have shown promise in terms of inhibiting tumor growth and disease progression,results to date have been modest in their ability to translate into meaningful clinical benefit.This review will serve as an updated report on the current state of literature concerning pre-clinical and clinical therapies being investigated for brainstem glioma.In addition,this review will serve as a guide for clinicians as we review the evolving nomenclature of brainstem gliomas,commonly presenting symptoms,diagnostic tools,and standard therapies.
